DossierENTITY

Dr Reddy's

Coverage of Dr Reddy's in the Nexus archive.

Earliest in view: Jul 24 · 02:24 UTCMost recent: Jul 30 · 06:24 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 30 · 06:24 UTCBLOOMBERG
Dr Reddy's CEO On Clogged Semaglutide Pipeline
Dr Reddy's CEO Erez Israeli anticipates strong performance in the second half of FY2026-27 after resolving semaglutide pipeline issues. He predicts intense competition in the semaglutide generics market, with over 20 companies vying for market share.
BUSINESSJul 24 · 02:24 UTCCNBC TOP
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
The CEO of Indian pharma company Dr Reddy's warned that Trump's proposed tariffs on generic drugs will increase their prices in the U.S. for patients.